Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EQT Corporation Common Stock (EQT) vs Eli Lilly And Co (LLY) Price & Performance

EQT Corporation Common StockTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

EQT Corporation Common Stock vs Eli Lilly And Co — how do they compare? EQT Corporation Common Stock trades at $52.99 (market cap $33.11B), while Eli Lilly And Co trades at $1,169.5 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 31.4× EQT Corporation Common Stock's market cap, and EQT Corporation Common Stock pays the higher dividend (1.25%). Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 0 Days and Eli Lilly And Co for 93 Days on average.

EQTLLY
Market Cap
$33.11B$1.04T
Volume
7,642,9593,064,878
Sector
EnergyHealth
52-Week High
$67.93$1.28K
52-Week Low
$48.56$799.57
Typical Hold Time
0 Days93 Days
Enterprise Value
$38.66B$1.09T
Dividend Yield
1.25%0.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EQT Corporation Common Stock

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,188.72, up 2.7% today, reflecting strong momentum driven by robust earnings beats and bullish technical signals. The stock exhibits impressive fundamentals with 2025 revenue of $65.18B and net income of $20.64B, yielding a net margin of 31.66%. Recent news highlights promising pipeline developments in weight-loss drugs, including EloraTZP, which outperformed Zepbound in trials, reinforcing its competitive edge in the obesity and diabetes markets.

Outlook remains positive given analyst consensus of a $1,350 price target and 73% buy ratings, though high valuation multiples (P/E 39.26) and rising debt-to-asset ratios (42.78% in 2024) warrant caution. Key risks include regulatory hurdles and intensifying competition from rivals like Novo Nordisk, but Lilly's innovation pipeline and market leadership position it for sustained growth.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EQT
100% Buy0% Sell
Avg holding period · 0 Days
LLY
69% Buy31% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About EQT Corporation Common Stock

EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.

Read more on EQT →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →